[On the treatment of lymphocytic meningitis].
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000666:Amphotericin B / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000995:Antitubercular Agents / Q000627:therapeutic use*; D005000:Ethionamide / Q000627:therapeutic use; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use; D008581:Meningitis / Q000134:cerebrospinal fluid / Q000188:drug therapy*; D008587:Meningitis, Viral / Q000188:drug therapy; D009181:Mycoses / Q000134:cerebrospinal fluid; D011379:Prognosis; D012507:Sarcoidosis / Q000134:cerebrospinal fluid / Q000188:drug therapy; D013299:Streptodornase and Streptokinase / Q000627:therapeutic use; D013307:Streptomycin / Q000627:therapeutic use; D013587:Syphilis / Q000134:cerebrospinal fluid / Q000188:drug therapy; D014390:Tuberculosis, Meningeal / Q000134:cerebrospinal fluid / Q000188:drug therapy*
D000305:Adrenal Cortex Hormones; D000900:Anti-Bacterial Agents; D000995:Antitubercular Agents; D000666:Amphotericin B; D013299:Streptodornase and Streptokinase; D005000:Ethionamide; D007538:Isoniazid; D013307:Streptomycin
Zur Therapie lymphozytärer Meningitiden.